IVTEAM
Magnesium sulfate extravasation – Full Text
"We present a case of vascular extravasation of magnesium sulfate, not known for causing tissue damage, which led to significant vascular injury” Bilodeau et al (2025).
Do you have news you would like to share on the NIVAS News Hub?
If you have an RSS feed you wish to share with up please contact us here.
Showing 121-132 of 640 results.
"We present a case of vascular extravasation of magnesium sulfate, not known for causing tissue damage, which led to significant vascular injury” Bilodeau et al (2025).
"The integration of ultrasound-guided vascular access into routine emergency protocols could enhance patient safety, satisfaction, and procedural efficiency in emergency care settings” Peralta-Gámez et al (2025).
"To identify risk factors for catheter-related bloodstream infections (CRBSI) in cancer patients, we compared 200 CRBSI cases to 400 controls” Haddad et al (2025).
"This study aimed to develop, validate, and apply an analytical method to detect and quantify 5-FU residues on the external surfaces of infusion pumps” Cardoso et al (2025).
"Insertion of a midline catheter (MLC) into the upper arm with tip positioned in the axillary vein may reduce the incidence of phlebitis. This study evaluated the safety and effectiveness of MLC use for continuous 5-FU infusion in cancer patients” Sakakida et al (2025).
"The authors aimed to examine the effect of three techniques used to improve vein prominence on achievement, knowledge, and psychomotor skills in the first PVC experience in nursing students” Yılmaz et al (2025).
"This study aimed to determine intensive care nurses' knowledge and attitudes towards preventing catheter-related bloodstream infections and their attitudes towards evidence-based practices” Gezginci Akpinar et al (2025).
"Twelve months after implementation, more than 100 patients with breast cancer participated with zero incidences of resulting lymphedema. There were no foot stick orders or calf blood pressures in patients when the ipsilateral arm was used. After 16 months, the practice change became a systemwide policy” Shady (2025).
"To calculate the rate of severe complications requiring surgical vascular intervention following vascular device implantation during the COVID-19 pandemic” Müller et al (2025).
"An easy-to-use nomogram for prediction of CRBSI in hemodialysis patients is well developed.This risk assessment tool can effectively identify patients at high risk of CRBSI and may be useful for optimizing catheter management” Wu et al (2025).
"The nasoenteral catheter was the most frequently removed device (44.4%), followed by the central venous catheter (11.4%), the indwelling bladder catheter (9.0%), and the peripheral venous catheter (6.9%)” Oliveira et al (2025).
"For uncuffed, non-tunneled dual-lumen catheters used for dialysis vascular access, the jugular insertion site does not demonstrate a reduced risk of CRBSI compared to the femoral site. However, jugular catheter placement is associated with a longer dwelling time and a lower mortality rate.” Phatpituk et al (2025).
